What is the main event reported in this 8-K filing?

The primary event is the announcement of a definitive Merger Agreement between Anthem, Inc. (now Elevance Health) and Cigna Corporation, whereby Anthem will acquire Cigna.

What is the updated financial outlook for Elevance Health in 2015?

Elevance Health expects its full-year 2015 net income to be greater than $9.75 per share, with adjusted net income expected to be greater than $10.00 per share, excluding certain net adjustment items and merger-related costs.

What is the purpose of the By-Law amendment mentioned in the filing?

The By-Law amendment designates the Marion Superior Court in Indiana (or the U.S. District Court for the Southern District of Indiana if the former lacks jurisdiction) as the sole and exclusive forum for certain legal actions against the company, unless the company consents otherwise.

Does the updated financial guidance include costs associated with the merger?

No, the provided guidance explicitly states that it does not include any future merger-related transaction costs. These costs are expected to be excluded from the company's adjusted net income calculation.

ELV 8-K: Earnings & Results, Corporate Changes & More

Summary

Elevance Health, Inc. (ELV), formerly Anthem, Inc., announced a significant event via an 8-K filing on July 24, 2015. The company entered into an Agreement and Plan of Merger with Cigna Corporation on July 23, 2015, through a wholly-owned subsidiary, to acquire all outstanding shares of Cigna. This represents a major strategic move for Elevance Health, aiming to significantly expand its market presence and capabilities. The filing also provided a preview of the company's second quarter 2015 financial results, reporting net income of $3.13 per share (adjusted net income of $3.10 per share excluding net gains). Furthermore, Elevance Health updated its full-year 2015 financial guidance, expecting net income to be greater than $9.75 per share (adjusted net income greater than $10.00 per share, excluding certain items). This guidance does not include merger-related transaction costs or other future adjustments. Additionally, the company's Board of Directors approved an amendment to its By-Laws, establishing a sole and exclusive forum for certain legal actions within the Marion Superior Court or the U.S. District Court for the Southern District of Indiana. This filing is crucial for investors as it outlines a transformative merger and provides updated financial outlook, while also detailing governance changes.

Key Highlights

1Anthem, Inc. (now Elevance Health) and Cigna Corporation entered into a Merger Agreement on July 23, 2015, for Anthem to acquire Cigna.
2The company reported preliminary second quarter 2015 net income of $3.13 per share (adjusted $3.10 per share).
3Full-year 2015 adjusted net income guidance was raised to greater than $10.00 per share.
4The updated full-year guidance excludes merger-related transaction costs and certain other net adjustment items.
5The company's Board of Directors approved an amendment to its By-Laws, designating a specific court as the exclusive forum for certain legal actions.
6The filing includes forward-looking statements regarding the merger and future financial performance, subject to various risks and uncertainties.

Elevance Health, Inc. 8-K Report, Financial Results (Jul 24, 2015)

Summary

Key Highlights

Frequently Asked Questions